Literature DB >> 19687181

Duloxetine for the treatment of recurrent major depressive disorder in elderly patients: treatment outcomes in patients with comorbid arthritis.

Madelaine M Wohlreich1, Mark D Sullivan, Craig H Mallinckrodt, Amy S Chappell, Tina M Oakes, John G Watkin, Joel Raskin.   

Abstract

BACKGROUND: Evaluation and treatment of major depression (MDD) in elderly patients is frequently complicated by the presence of comorbid medical conditions, which can reduce the effect of depression treatment, leading to lower rates of depressive-symptom improvement and higher rates of relapse.
OBJECTIVE: The authors investigated results of antidepressant concurrent with arthritis pain treatment in elderly patients.
METHOD: Patients age 65 and over with recurrent MDD were stratified by arthritis status and randomized to duloxetine (a dual reuptake-inhibitor of serotonin and norepinephrine) or placebo treatment for 8 weeks (duloxetine, N=117; placebo, N=55).
RESULTS: Duloxetine significantly reduced MDD symptom severity in elderly patients with and without arthritis, and produced significant reduction in several pain measures in those patients with comorbid arthritis. DISCUSSION: The magnitude and time-course of depressive symptom improvement did not differ significantly between patients with and without arthritis. Some studies have suggested that the severity of pain in arthritis patients may be linked to depression severity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19687181     DOI: 10.1176/appi.psy.50.4.402

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  9 in total

1.  Comparing Patient-Reported Outcomes Measure Information System Depression Scale with Legacy Depression Measures in a Community Sample of Older Adults with Varying Levels of Cognitive Functioning.

Authors:  Jennifer B Levin; Michelle E Aebi; Kathleen A Smyth; Curtis Tatsuoka; Johnny Sams; Thomas Scheidemantel; Martha Sajatovic
Journal:  Am J Geriatr Psychiatry       Date:  2015-04-22       Impact factor: 4.105

Review 2.  Duloxetine: a review of its use in the management of major depressive disorder in older adults.

Authors:  Sohita Dhillon
Journal:  Drugs Aging       Date:  2013-01       Impact factor: 3.923

Review 3.  Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients.

Authors:  Christian Dolder; Michael Nelson; Andrea Stump
Journal:  Drugs Aging       Date:  2010-08-01       Impact factor: 3.923

Review 4.  Antidepressants for hip and knee osteoarthritis.

Authors:  Alexandra A Leaney; Jenna R Lyttle; Julian Segan; Donna M Urquhart; Flavia M Cicuttini; Louisa Chou; Anita E Wluka
Journal:  Cochrane Database Syst Rev       Date:  2022-10-21

5.  Effects of pain and prescription opioid use on outcomes in a collaborative care intervention for anxiety.

Authors:  Peter Roy-Byrne; Mark D Sullivan; Cathy D Sherbourne; Daniela Golinelli; Michelle G Craske; Greer Sullivan; Murray B Stein
Journal:  Clin J Pain       Date:  2013-09       Impact factor: 3.442

6.  Use of non-opioid analgesics as adjuvants to opioid analgesia for cancer pain management in an inpatient palliative unit: does this improve pain control and reduce opioid requirements?

Authors:  Shivani Shinde; Pamela Gordon; Prashant Sharma; James Gross; Mellar P Davis
Journal:  Support Care Cancer       Date:  2014-08-29       Impact factor: 3.603

Review 7.  Expert consensus of Chinese Association for the Study of Pain on the non-opioid analgesics for chronic musculoskeletal pain.

Authors:  Dong Huang; Yan-Qing Liu; Ling-Jie Xia; Xian-Guo Liu; Ke Ma; Guang-Zhao Liu; Li-Zu Xiao; Tao Song; Xiao-Qiu Yang; Zhi-Jian Fu; Min Yan
Journal:  World J Clin Cases       Date:  2021-03-26       Impact factor: 1.337

8.  An open treatment trial of duloxetine in elderly patients with dysthymic disorder.

Authors:  Nancy Kerner; Kristina D'Antonio; Gregory H Pelton; Elianny Salcedo; Jennifer Ferrar; Steven P Roose; Dp Devanand
Journal:  SAGE Open Med       Date:  2014-05-08

9.  Analysis of Antidepressant, Benzodiazepine Anxiolytic, and Hypnotic Use When Treating Depression, Anxiety, and Aggression in Pain Clinic Patients Treated for Neuropathic Pain.

Authors:  Marcin Kolacz; Dariusz Kosson; Ewa Puchalska-Kowalczyk; Malgorzata Mikaszewska-Sokolewicz; Barbara Lisowska; Malgorzata Malec-Milewska
Journal:  Life (Basel)       Date:  2022-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.